Investment Committee Summary
| Rating | HOLD |
| Internal 5-tier | HOLD |
| Classification · conviction | quality defensive · medium |
| Evidence | 8/8 load-bearing inputs sourced |
| Triangulated fair value | $76.05 (+2% vs spot · triangulated FV) |
| 12-mo scenario PWEV | $84.31 (+14% vs spot · 12m PWEV) |
| Next catalyst | 2026-11-12 — Capacity / fab-utilisation and Fab-2 / Fab-4 ramp update |
| Primary thesis-break | Sequential revenue growth (quarter-on-quarter) < -0.05 (2 consecutive prints) |
Decision detail — rating tables & Research OS strip
Rating: HOLD
Internal 5-tier: HOLD · quality defensive · analyst conviction: medium
| Metric | Value |
|---|---|
| Current Price | $74.21 |
| Triangulated Fair Value | $76.05 (+2% vs spot · triangulated FV) |
| 12-mo Scenario PWEV | $84.31 (+14% vs spot · 12m PWEV) |
| Forward P/E | 25.2x |
| Market Cap | $43B |
| 52-Week Range | $47.57–$105 |
EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).
Methodology: Valuation triangulated across three weighted anchors — an intrinsic DCF, a scenario-weighted PWEV and a Monte Carlo median (Student-t + regime switching). Anchors that share a market multiple are not independent evidence and are weighted as one view. Figures reconciled to Alpha Vantage 2026-08-24. Each chart below sits with the part of the thesis it evidences.
General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.
Decision Support — Research OS jump to detail ↓
| Research conviction | Exp. return (1y) | Rules stance | Preferred options | Next catalyst |
|---|---|---|---|---|
| 57.1/100 (44th pct) | +14% 1yr expected | Hold | Call Debit Spread | 79d — Capacity / fab-utilisation and Fab-2 / Fab-4 ramp update |
Full breakdown — conviction components, position sizing, probability-return distribution, decision rules, factor & portfolio interaction, options intelligence and the catalyst timeline — in the Decision Support sections below. Model output for research; not individualised advice.
📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.
Recommendation: HOLD
Balanced: triangulated fair value $76.05 (+2% vs spot); the outcome hinges on P/E Multiple. The debate is P/E Multiple — fundamentally a multiple/regime call.
Investment Thesis
At $74.21 on 25 August 2026, on roughly 25 times forward earnings, the market prices Microchip for a clean mid-cycle recovery: revenue back to trend, an operating margin restored toward 38%, and datacenter content offsetting the automotive and industrial down-legs. The engine is more cautious. Triangulated fair value of $76.05 stands +2% against spot, the probability-weighted expected value is $84.31 and the twelve-month target is $88.50; the shares are fairly valued against the weighted anchors, which is what produces the HOLD. The discounted-cash-flow anchor sits well under the multiple-driven view, and that gap is the tell: the current price already discounts most of the recovery it is being asked to deliver. Simulated variance is dominated by the multiple rather than the earnings path, so the outcome hangs on a re-rating holding rather than on the numbers themselves; the base case lands close to the quote, and the structural down-case sits below the 52-week low by construction. The single most damaging risk is capital allocation: trailing free cash flow no longer covers the dividend, so a China-plus-inventory shock that stalls the recovery would strain the payout against net debt of ~$5.3B.
Narrative drafted 2026-08-16 by claude-opus-5 under supervision; reviewed by Marinus 2026-08-16.
The dashboard below is the whole argument on one page: spot ($74.21) against each valuation anchor, the scenario tree, technicals and the options-implied move.
Anti-Thesis (The Real Bear Case)
The highest-probability bear case is a semiconductor downturn: capital-spending digestion combined with China and export-control loss. The mechanism is concrete. Datacenter and industrial customers over-ordered into the build-out; as they work inventory down, bookings stay below shipments and fab utilisation falls. Under-utilisation charges drag gross margin, compressing the operating margin well below the level near 38% the base case assumes — an owned-fab model levers both ways. Simultaneously, export controls and Chinese domestic substitution permanently displace a slice of demand rather than deferring it, so the recovery arrives against a smaller addressable base than the one that was lost. Earnings and the multiple then compress together, driving the structural target below the 52-week low. With the dividend already exceeding trailing free cash flow and net debt of ~$5.3B on the balance sheet, this is the scenario that forces a capital-allocation reckoning rather than a patient wait for the cycle.
Key Debate
P/E Multiple explains 78% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.
What the Market Is Pricing In
At the current price, the market pays 20.3× consensus forward EPS, vs the house DCF terminal 26.0×, and a peer median 27.8×. The house DCF sits 7% below spot, so the market is pricing in more than the house case — roughly 0.7pp of revenue CAGR.
Variant perception: the house view is below-consensus, and the thesis is primarily event-driven.
| Metric | Consensus | House | Importance |
|---|---|---|---|
| Revenue | 6.4 | 5.2 | High |
| EPS | 3.7 | 3.0 | Medium |
| Target price | 109.2 | 88.5 | Medium |
Scenario Analysis
The scenario tree spans a structural 'Structural — AI-Capex Digestion / China / Export Controls' downside ($39.10) to a 'Bull — Supercycle Re-Rate' bull case ($148); the probability-weighted blend (PWEV $84.31) is +14% versus spot.
| Scenario | Probability | Target | Return vs spot |
|---|---|---|---|
| Structural — AI-Capex Digestion / China / Export Controls | 20% | $39.10 | -47% |
| Cyclical Downturn — Inventory Correction | 17% | $61.80 | -17% |
| Base — Mid-Cycle + AI Content | 35% | $88.40 | +19% |
| Upcycle — AI / Datacenter Demand | 20% | $116 | +56% |
| Bull — Supercycle Re-Rate | 8% | $148 | +99% |
| Probability-Weighted (PWEV) | — | $84.31 | +14% |
Share-count charge: none applied. The probability-weighted value above is the gross per-share figure — no annual dilution is deducted — stock-based compensation runs at 5.4% of revenue; free cash flow net of SBC is $0.62B. SBC is therefore disclosed, not charged: read the per-share figures as before dilution.
Scenario rationale — the driver path behind every target:
- Structural — AI-Capex Digestion / China / Export Controls (20%, $39.10). Structural impairment — AI-capex digestion / China / export controls: earnings AND the multiple compress together. Target sits below the 52-week low by construction.
- Cyclical Downturn — Inventory Correction (17%, $61.80). Cyclical downturn — chip demand (AI/datacenter, auto, mobile) + the semi cycle + China / export controls weakens for 1–2 years before normalising.
- Base — Mid-Cycle + AI Content (35%, $88.40). Mid-cycle — normalised chip demand (AI/datacenter, auto, mobile) + the semi cycle + China / export controls; disciplined capital allocation; steady returns.
- Upcycle — AI / Datacenter Demand (20%, $116). Upside — AI + datacenter demand supercycle lifts earnings above mid-cycle; the multiple expands modestly.
- Bull — Supercycle Re-Rate (8%, $148). Upside tail — sustained tight conditions or a structural re-rate on AI + datacenter demand supercycle.
Valuation Triangulation
Three weighted anchors — an intrinsic dcf, a scenario-weighted pwev and a monte carlo median (student-t + regime switching) — read them with their basis in mind. The Monte Carlo, the DCF terminal and any peer re-rate key off a market multiple, so they are not fully independent; only discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat three numbers as three independent votes.
| Method | Basis | Fair Value | vs Spot | Weight in this name's blend |
|---|---|---|---|---|
| Monte Carlo median (Student-t + regime) | multiple | $79.24 | +7% | 20% (declared 15%) |
| Peer EV/Revenue re-rate | multiple | $131 | +77% | 0% — cross-check only |
| Scenario PWEV | multiple | $84.31 | +14% | 33% (declared 25%) |
| DCF (5-year + terminal) | cash flow + terminal × | $68.78 | -7% | 47% (declared 35%) |
| Triangulated (weighted) | — | $76.05 | +2% | 100% |
The house blend DECLARES five anchor weights — DCF 35%, scenario PWEV 25%, Monte Carlo 15%, sum-of-parts 15%, peer re-rate 10%. For this name sum-of-parts, peer P/E re-rate are not computed, so 25% of the declared weight is redistributed across the anchors that exist — which is why the weights above differ from the declared ones. The fair value is unaffected by this disclosure; the blend has always worked this way.
Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.
Monte Carlo — the outcome distribution
10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $79.24 and 56% of paths finish above spot. The variance decomposition shows the p/e multiple is the dominant swing factor (78% of variance). Value is a multiple bet: fundamentals move the answer far less than the rating does.
DCF — the cash-flow anchor
Independent of the market multiple: a 5-year path, WACC 10.0%, 26.0x terminal FCF multiple → $68.78. This anchor is deliberately the heaviest (47%): it is the valuation least hostage to the current multiple regime.
Peer benchmarking — relative value
Against the peer cohort, re-rating to the peer-median EV/Revenue multiple implies $131; the peer-median forward P/E is 27.8x, but the engine carries no P/E-implied price for this name (no forward-EPS basis at the peer step). A premium is only justified by superior growth/margins; otherwise it is multiple risk. Excluded from the weighted blend — shown only as a market cross-check.
Across all anchors the spread is 74% of the median — wide (genuine disagreement — the blend carries low valuation confidence).
Sensitivity
DCF/share — WACC × terminal multiple
| WACC \ Term× | 18.2x | 22.1x | 26.0x | 29.9x | 33.8x |
|---|---|---|---|---|---|
| 8.0% | $54.54 | $65.13 | $75.73 | $86.32 | $96.91 |
| 9.0% | $51.93 | $62.05 | $72.16 | $82.28 | $92.39 |
| 10.0% | $49.45 | $59.12 | $68.78 | $78.45 | $88.11 |
| 11.0% | $47.10 | $56.34 | $65.58 | $74.82 | $84.05 |
| 12.0% | $44.87 | $53.71 | $62.54 | $71.37 | $80.20 |
DCF/share — revenue CAGR Δ × op-margin Δ
| CAGRΔ \ MgnΔ | -3.0pp | -1.5pp | +0.0pp | +1.5pp | +3.0pp |
|---|---|---|---|---|---|
| -3.0pp | $53.16 | $55.74 | $58.32 | $60.90 | $63.48 |
| -1.5pp | $57.90 | $60.65 | $63.41 | $66.17 | $68.92 |
| +0.0pp | $62.90 | $65.84 | $68.78 | $71.72 | $74.67 |
| +1.5pp | $68.18 | $71.32 | $74.45 | $77.59 | $80.73 |
| +3.0pp | $73.75 | $77.09 | $80.43 | $83.78 | $87.12 |
Tornado — DCF/share swing by driver (widest first)
| Driver | Low | High | Swing |
|---|---|---|---|
| Revenue CAGR ±3pp | $58.00 | $80.00 | $22.00 |
| Terminal × ±15% | $59.00 | $78.00 | $19.00 |
| Op margin ±3pp | $63.00 | $75.00 | $12.00 |
| WACC ±1pp | $66.00 | $72.00 | $7.00 |
| Capex intensity ±15% | $67.00 | $71.00 | $4.00 |
Company lever — SoP/share vs Semiconductors multiple (AI re-rating) (base 30.0x)
| Multiple | 21.0x | 25.5x | 30.0x | 34.5x | 39.0x |
|---|---|---|---|---|---|
| SoP/share | $57.00 | $71.00 | $86.00 | $100 | $114 |
Peer Quality & Weighting
| Peer | Fwd P/E | Growth | Op margin | Quality | Weight cap |
|---|---|---|---|---|---|
| NVDA | 22.7× | 10% | 66% | direct | 100% |
| AVGO | 33.0× | 10% | 49% | segment | 50% |
| MU | 10.5× | 10% | 68% | segment | 50% |
| TXN | 39.8× | 10% | 38% | segment | 50% |
Quality-weighted forward P/E: 25.7× (simple median 27.8×). Direct peers count 100%, segment 50%, broad 25%.
Historical-range cross-check: 52-week range $47.57–$105, centre $70.80 (-5% vs spot); spot sits at the 46th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.
Risk / Reward & Margin of Safety
| Metric | Value |
|---|---|
| Upside to triangulated FV | $76.05 (+2% vs spot · triangulated FV) |
| Downside to bear case (Structural — AI-Capex Digestion / China / Export Controls) | $39.10 (-47% vs spot · bear scenario) |
| Reward/risk ratio | 0.1× |
| Margin of safety (FV vs spot) | +2% |
| P(price > spot) — Monte Carlo | 56% |
Reward/risk compares triangulated upside against the probability-weighted bear target, not the extreme tail. Bull case (Bull — Supercycle Re-Rate): $148.
Company Overview & Business Model
Microchip Technology Inc — TECHNOLOGY · SEMICONDUCTORS. Microchip Technology Inc. is a publicly-listed American corporation that manufactures microcontroller, mixed-signal, analog and Flash-IP integrated circuits.
How it makes money.
| Segment | Rev mix | Growth | Op margin | Key driver |
|---|---|---|---|---|
| Semiconductors | 100% | +10% | 38% | chip demand (AI/datacenter, auto, mobile) + the semi cycle + China / export controls |
Edge. Narrow moat. Authored moat rationale withheld pending re-authoring.
Revenue-Segment Breakdown
The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)
| Segment | Revenue | Mix | Growth | Op margin | EBIT | Multiple | Capex % | Tag |
|---|---|---|---|---|---|---|---|---|
| Semiconductors | $4.7B | 100% | 10% | 38% | $1.8B | 30.0x | 10% | ESTIMATE |
| EBIT = segment revenue × operating margin (segment EBITDA not shown — per-segment D&A is not separately disclosed). |
Named Exposures
Demand & pricing cycle (FACT/ESTIMATE)
| Dimension | Assessment |
|---|---|
| driver | chip demand (AI/datacenter, auto, mobile) + the semi cycle + China / export controls |
| net_debt_or_cash_b | -5.29 |
Capital intensity & shareholder returns (ESTIMATE)
| Dimension | Assessment |
|---|---|
| capex_pct_revenue | 0.1 |
| div_yield | 0.0195 |
Structural risk vs optionality (INFERENCE)
| Dimension | Assessment |
|---|---|
| downside | AI-capex digestion / China / export controls |
| upside | AI + datacenter demand supercycle |
Balance Sheet & Liquidity
| Metric | Value |
|---|---|
| Net debt | $5.3B — highly levered |
| Net debt / EBITDA | 3.52x |
| Interest coverage (EBIT / interest) | 3.2x |
| Current ratio | 2.09x |
| Lease obligations | $0.0B |
| Cash & ST investments | $0.2B |
Balance-sheet data as of 2026-03-31 (Alpha Vantage).
Capital Allocation
| Metric | Value |
|---|---|
| Free cash flow | $0.9B |
| Buybacks / dividends | $0.2B / $1.1B |
| Total shareholder yield | 3.0% |
| Payout as % of FCF | 146.4% |
| Reinvestment (capex / OCF) | 9.5% |
| SBC as % of FCF | 29.3% |
| Allocation stance | returning more than FCF (balance-sheet funded) |
Free-Cash-Flow Quality
| Metric | Value |
|---|---|
| FCF margin | 18.5% |
| FCF conversion (FCF / net income) | 378.7% |
| FCF yield | 2.0% |
| Capex intensity (capex / revenue) | 1.9% |
| FCF − SBC (diagnostic) | $0.6B |
| Capex split (maint / growth) | 40% / 60% — IDM fab model; capex ramps off a trough as utilisation recovers — the majority is growth/capacity (fab expansion, equipment) with the balance maintaining existing fabs |
Accounting quality: SBC 1% of revenue; cash conversion (OCF/NI) 418% — cash-backed.
Competitive Moat
Moat sources:
- FACT: embedded MCU + analog design-ins carry long product lifecycles and high switching cost once designed into a board
- FACT: >120,000 customers and a broad catalog reduce single-customer concentration
- INFERENCE: the IDM (own-fab) model gives supply control but adds fixed-cost cyclicality vs fabless peers
- ABSENCE: no process-node leadership and limited AI/datacenter content vs NVDA/AVGO — the AI narrative is adjacency, not core
Earnings-Call Disconfirmation & Sentiment
Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.
Management vs analyst tone (2026Q3): management +0.47 vs analyst floor +0.21 → delta +0.26 (n=38 mgmt / 25 Q&A; 21st pctile across the S&P book, z -0.9).
Flag: TYPICAL — management-vs-analyst tone within the normal cross-sectional range.
| Quarter | Mgmt | Analyst | Delta |
|---|---|---|---|
| 2026Q3 | +0.47 | +0.21 | +0.26 |
| 2026Q2 | +0.40 | +0.20 | +0.20 |
| 2026Q1 | +0.45 | +0.35 | +0.10 |
| 2025Q4 | +0.49 | +0.32 | +0.17 |
News (last 365d, 1405 articles): avg ticker sentiment +0.22 (bullish 33% / bearish 3%)
Consensus & Market Expectations
| Reference | Value |
|---|---|
| Street target (mean) | $109 (+47% vs spot · street) |
| House target | $88.50 (-19.0% vs street) |
| Sell-side coverage | 25 analysts (SB 2 / B 17 / H 6 / S 0 / SS 0; net score 0.42) |
| Consensus FY EPS | $3.65 (reference only — house values on EV/EBITDA) |
| Consensus FY revenue | $6.4B; house below (-18.7%) |
_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.
Catalyst Calendar
- 2026-11-12 (~80d) — Capacity / fab-utilisation and Fab-2 / Fab-4 ramp update (authored)
- 2027-03-31 (~219d) — Fiscal-year-end results + 9-point business-recovery-plan progress checkpoint (authored)
Forecast Track Record
- EPS surprise: beat 75% of the last 8 quarters; average surprise +1.8%.
- Prior-forecast backtest (12 snapshots, 2026-06-27→2026-08-20): directional hit-rate 8%; mean predicted +10.9% vs realised -7.0%. Disconfirming track record is reported, not suppressed.
Catalyst Timeline
5 catalysts in the next 90 days (of 14 tracked). Importance 1–3; confidence 0–1.
| When | Catalyst | Type | Importance | Confidence |
|---|---|---|---|---|
| 2026-09-16 (in 22d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2026-09-18 (in 24d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2026-10-14 (in 50d) | September CPI | macro | ●● | 0.8 |
| 2026-10-28 (in 64d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2026-11-12 (in 79d) | Capacity / fab-utilisation and Fab-2 / Fab-4 ramp update | authored | ● | 0.7 |
| 2026-12-09 (in 106d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2026-12-18 (in 115d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2027-01-27 (in 155d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2027-03-17 (in 204d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2027-03-19 (in 206d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2027-03-31 (in 218d) | Fiscal-year-end results + 9-point business-recovery-plan progress checkpoint | authored | ● | 0.7 |
| 2027-04-28 (in 246d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2027-06-09 (in 288d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2027-06-18 (in 297d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
_Sources: extended.catalysts, data/catalysts/
Regulatory & Legal Risk
| Issue | Probability | Valuation sensitivity | Horizon |
|---|---|---|---|
| US-China export controls / entity-list expansion restricting China-facing embedded/analog sales | medium (~40%) | medium - China is a material end-market ~5% of FV | 12-24m |
| Tariffs / reshoring incentives (CHIPS-adjacent) altering fab economics and customer supply routing | medium (~35%) | low - IDM footprint is largely US ~2% of FV | 12-24m |
Probabilities and sensitivities are analyst estimates, not market-implied.
Scenario Macro & Key Risks
| Scenario | Macro assumption | Key risk |
|---|---|---|
| Structural — AI-Capex Digestion / China / Export Controls | AI-capex digestion drags broad-based semis, China demand is lost to export controls and local substitution, and the embedded cycle stays depressed | permanent China share loss plus prolonged fab under-utilisation structurally impairs gross margin |
| Cyclical Downturn — Inventory Correction | A 1-2 year inventory correction across auto/industrial/mobile embedded end-markets before restock | under-utilisation charges persist longer than modeled, deepening the margin trough |
| Base — Mid-Cycle + AI Content | Mid-cycle: inventory normalises, book-to-bill returns above 1.0, modest AI/datacenter content adds | the recovery is shallower and later than assumed, delaying margin normalisation |
| Upcycle — AI / Datacenter Demand | A broad semi upcycle with rising AI/datacenter connectivity and power content lifts volume and utilisation | Microchip's AI content is thinner than peers', so it under-participates in the upcycle |
| Bull — Supercycle Re-Rate | A multi-year supercycle plus a growth-multiple re-rate on peak-cycle earnings | the re-rate capitalises cyclical-peak margins into a terminal multiple the narrow moat cannot sustain |
Decision Rules (Machine-Checked)
Stance: Hold — 1 bullish / 0 bearish / 0 caution rules triggered of 6 evaluable (0 lacked data).
| Rule | Condition | Observed | Triggered |
|---|---|---|---|
| R1-valuation-stretch | expected return vs fair value < -12 (upside_pct) |
19.26 | no |
| R2-valuation-opportunity | expected return vs fair value > 15 (upside_pct) |
19.26 | YES |
| R3-street-revisions | street net rating stance < -0.25 (extended.consensus.street_score) |
0.42 | no |
| R4-earnings-quality | cash conversion of earnings < 80 (extended.accounting_quality.cash_conversion_pct) |
418.3 | no |
| R5-technical-breakdown | price vs 200-day SMA < 0.85 (technicals.sma_200) |
0.98 | no |
| R6-vol-regime-shift | IV/RV vol-risk premium > 1.4 (options_overlay.iv_rv) |
0.79 | no |
Machine-checked rules over disclosed inputs. The authored falsification triggers elsewhere in this report are analyst judgment and are NOT evaluated here. The stance is a portfolio-management signal and does not modify the published research rating.
Reasons the Thesis Could Fail (Falsifiable)
Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:
- Sequential revenue growth (quarter-on-quarter) < -0.05 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
- Non-GAAP gross margin < 0.58 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
- Book-to-bill ratio < 0.9 (2 consecutive prints). A book-to-bill below parity for two quarters confirms orders are not replacing shipments, validating the inventory-correction mechanism and lengthening the down-leg.
- China revenue share of total < 0.18 (2 consecutive prints). A sustained fall in China exposure below the high-teens would confirm export-control and localisation displacement is permanent rather than a timing effect, feeding the Structural scenario.
- Trailing free cash flow less dividends paid < 0.0 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
Fact / Inference / Speculation
- FACT: Spot $74.21; 52-week range $47.57–$105; engine rating HOLD; house target $88.50 (+19%). (source: Alpha Vantage 2026-08-24, 25 August 2026)
- INFERENCE: Triangulated FV $76.05 (+2% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits below the multiple-discipline core.
- SPECULATION: At current prices the embedded bet is that the market keeps paying the current multiple through the capex cycle — a regime call the engine cannot verify from fundamentals alone.
Conviction Score
Research Conviction measures the strength and quality of the research setup — input coverage, financial quality, valuation support, process agreement. It is NOT the probability that the recommendation succeeds; the forecast track record section is the evidence on that.
57.1/100 (confidence band 44.7–69.5), 44th percentile of 858 covered names (as of 2026-08-24). Weighted composite under config ros-1.19.0 — every component and its inputs below.
| Component | Score (0–100) | Weight | Inputs |
|---|---|---|---|
| business quality | 64 | 15% | extended.fcf_quality.fcf_margin_pct, extended.balance_sheet.net_debt_to_ebitda, extended.accounting_quality.cash_conversion_pct |
| financial strength | 21 | 10% | extended.balance_sheet.net_debt_to_ebitda, extended.balance_sheet.interest_coverage |
| valuation | 69 | 15% | upside_pct |
| growth | 67 | 10% | reconciliation.ttm_revenue_billions, reconciliation.fy_guide_revenue_billions |
| earnings visibility | 75 | 10% | extended.forecast_accuracy.eps_surprise.beat_rate_pct |
| moat | 60 | 10% | enrichment.moat.rating |
| technical trend (heuristic — no validation record; weight change reserved for AM-060) | 26 | 10% | technicals.rsi, technicals.sma_50, technicals.sma_200 |
| macro tailwinds | — | 10% | industry_context.house |
| risk profile | 65 | 10% | monte_carlo.prob_above_current, monte_carlo.p10, monte_carlo.p90, monte_carlo.median |
Missing inputs (macro tailwinds) are excluded and the remaining weights renormalised; the confidence band widens accordingly.
Score history: 58.7 → 58.7 → 65.7 → 59.2 → 59.2 → 57.0 → 56.9 → 56.9.
Probability-Weighted Return Profile
Horizon: 1 year — at this horizon CAGR equals total return by definition. Expected values are the probability-weighted sums over the full scenario set below.
| Scenario | Probability | Target | Total return | Contribution |
|---|---|---|---|---|
| Structural — AI-Capex Digestion / China / Export Controls | 20% | $39.10 | -47.3% | -9.5pp |
| Cyclical Downturn — Inventory Correction | 17% | $61.80 | -16.7% | -2.8pp |
| Base — Mid-Cycle + AI Content | 35% | $88.40 | +19.1% | +6.7pp |
| Upcycle — AI / Datacenter Demand | 20% | $116 | +56.3% | +11.3pp |
| Bull — Supercycle Re-Rate | 8% | $148 | +99.4% | +8.0pp |
| Aggregate | Value |
|---|---|
| Expected return (gross, 1y) | +13.6% |
| Expected return net of SBC dilution | +13.6% |
| Outcome dispersion (σ, from MC p10–p90) | 47.9% |
| Expected Sharpe (rf 4%) | 0.20 |
| Downside expectation (prob-weighted loss branches) | -12.3% |
The gross expected return is the probability-weighted scenario return (it reconciles to the gross PWEV); the diluted figure applies the SBC share-count charge and matches the published PWEV-based target.
Expected Alpha
Expected return minus the return this name is REQUIRED to deliver for its risk (1-year horizon). Constants are pre-registered (preregistered-static (amendment #2, 2026-07-29); not fitted to MCH outcomes).
| Component | Value |
|---|---|
| Expected return (gross, 1y) | 13.6% |
| Risk-free rate | 4.01% (1y proxy (3m/2y midpoint; AV lacks a 1y tenor), as of 2026-08-13) |
| Beta (shrunk, 1y vs SPY) | 1.75 (as of 2026-08-24) |
| Equity risk premium | 4.5% |
| Required return | 11.9% |
| Expected alpha | +1.7% |
| Alpha per unit risk (EA/σ) | +0.04 |
A negative expected alpha does not change the rating — it says the expected return does not clear the risk-adjusted hurdle at today's price. Rating mechanics are unchanged by this section.
Probability Cross-Checks
Not authoritative. The scenario probabilities in this report are AUTHORED — a judgement about how the world might go, not a measurement. Nothing below modifies them, the target, the rating or any position size. These checks ask only whether anything outside our own model agrees with us; where it does not, that is information for the reader, not a correction we have quietly applied.
| Cross-check | Ours | Comparator | Reading |
|---|---|---|---|
| Scenario spread vs options market | 43.2% (1σ) | 37.2% implied | broadly consistent with the market's implied uncertainty |
| Mass above spot: scenarios vs our own MC | 63.0% | 56.1% | the two expressions of our own view agree |
| Realised scenario frequency | 23 dated anchors | — | 23 dated anchors available; realised-vs-prior comparison is now meaningful. |
Authored set: 5 scenarios, probabilities summing to 1.0, mean target $84.31.
Factor Exposures
Cross-sectional percentiles over 858 covered names (style scores sector-demeaned; thematic = return-beta to the theme's proxy ETF). 50 = estate median.
| Style | Percentile | Theme | Percentile | |
|---|---|---|---|---|
| Growth | 16 | AI | 96 | |
| Value | 86 | Cloud | 69 | |
| Quality | 26 | Semis | 97 | |
| Momentum | 29 | Consumer | 94 | |
| Low-Vol | 27 | Rates | 68 | |
| USD | 14 | |||
| Energy | 20 |
Market interaction: correlation vs SPY +0.65, vs QQQ +0.66 (trailing ~1y daily returns).
Options Intelligence
Preferred structure: Call Debit Spread. The selector reads the equity view (direction) and the volatility surface — nothing here re-prices the chain.
- bullish with cheap options — buy defined-risk upside; a debit spread caps cost vs an outright call
- Direction bullish from the overlay conviction/rating (read-only input).
- IV/RV at the 12th percentile of the cross-section → low vol bucket. This is the measure that selects the structure above: it ranks how rich this name's implied vol is against its own realised vol, relative to other names.
- Reported alongside and not used to select: this name's own ATM IV sits at the 58th percentile of its own month-end history (decile 6). The two measures disagree here — vol is high for this name by its own history while its options are not unusually rich against its realised vol. Where they diverge, the cross-sectional measure is the one acting.
- IV term structure is in contango (longer-dated richer, slope +6.9pp) — favour longer-dated ownership (LEAPS) or calendars that are long the cheaper front.
IV term structure (contango, slope +6.9pp): 32-DTE 47% · 116-DTE 52% · 389-DTE 54%
| Priced structure | Value |
|---|---|
| Legs | Long 75 C, Short 85 C |
| Expiry | 2027-06-17 |
| Max loss | $3.65 |
| Max profit | $6.35 |
| Net debit | $3.65 |
| Return on risk | 174.0% |
| Breakeven | $78.65 |
Economics copied verbatim from the options overlay (priced from the listed chain (EOD marks)); the selector does not re-price.
Alternatives: LEAPS, Long Stock. IV rank shown via the name's own monthly IV history (advisory); structure selected on the cross-sectional IV/RV percentile. Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.
Position Sizing Framework
| Parameter | Value |
|---|---|
| Initial position | 0.50% NAV |
| Maximum position | 0.83% NAV |
| Risk budget | 1.36% NAV |
| Annualized outcome σ (MC) | 47.9% |
| Indicative holding period | 6–18 months |
| Liquidity | high, ~$838M ADV (adv usd 21 (split-adjusted 21d average, AM-046)), ~0.1 days to exit |
| Rebalancing trigger | position drifts ±25% from target weight, or the decision-rules stance changes |
Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.
Options Overlay
A defined-risk way to express the HOLD equity view. Chain as of 2026-08-24 — end-of-day marks — indicative, not executable quotes.
Market signals — ATM IV 47.3% (moderate regime) · expected move ±11.0% (2026-09-25) · put/call OI 0.59 · ATM Δ 0.55 / Θ -0.07 / ν 0.09. Direction: LONG (implied return +2.5% to triangulated fair value $76.05).
Bull Call Spread (Bullish) — Long 75 C / Short 85 C · 2027-06-17 · net debit $3.65 · max profit $6.35 · breakeven $78.65 · RoR 174.0% · max loss $3.65 · priced from the listed chain (EOD marks)
Defined-cost leverage to the fair-value gap: the debit is the entire downside, in exchange for participation between the strikes — a way to lean into upside without paying full call premium. Illustrative — no outcome is implied or guaranteed.
Long Call (LEAPS) (Bullish) — Long 75 C · 2027-06-17 · premium $13.8 · breakeven $88.80 · max loss $13.80 · priced from the listed chain (EOD marks)
Pure defined-risk directional exposure — the premium is the whole downside while the full upside is retained. A capped, known cost as an alternative to owning the shares outright.
Put Spread (income) (Bullish / income) — Short 67 P / Long 65 P · 2026-10-02 · net $0.47 · net entry $66.53 · yield 0.7% · RoR 31.0% · max loss $1.53 · priced from the listed chain (EOD marks)
Gets paid to wait for a lower entry, with the tail capped: the sold put collects premium while the cheaper long wing below it caps the maximum loss at the spread width — a defined-risk alternative to a naked cash-secured put.
Indicative options structures — a defined-risk expression of the equity view, model-and-market illustrated from the last-close chain. NOT personalised advice or an executable quote; premiums, IV and greeks move intraday. Options carry the risk of total loss of premium. Not a registered financial adviser.
Rating Bridge
Rating = HOLD because:
- Probability-weighted scenario value implies +14% vs spot
- Monte Carlo median implies +7% vs spot
- DCF fair value implies -7% vs spot — but this is terminal-value sensitive (exit-multiple $68.78 vs Gordon $38.22, 44% apart), so it carries less weight
- Bear case (Structural — AI-Capex Digestion / China / Export Controls) downside is -47% vs spot
- Net: reward/risk of 0.1× is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.
Model Appendix
DCF — line items
| Year | Revenue | Op income | − Capex | + D&A | FCF | PV(FCF) |
|---|---|---|---|---|---|---|
| FY+1 | $5B | $2B | $0B | $0B | $2B | $2B |
| FY+2 | $6B | $2B | $0B | $0B | $2B | $2B |
| FY+3 | $6B | $3B | $0B | $0B | $2B | $2B |
| FY+4 | $6B | $3B | $0B | $0B | $2B | $1B |
| FY+5 | $7B | $3B | $0B | $0B | $2B | $1B |
| Terminal | — | — | — | — | $2B × 26.0x | $37B |
FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 10% of revenue, weighted from the segments) — not a single conversion fudge.
WACC 10.0% · Σ PV(FCF) $8B + PV(terminal) $37B = EV $45B; − net debt $5.3B → equity $39B ÷ diluted shares $0.57B = $68.78/share (exit-multiple terminal).
- Gordon terminal at 2.5% → $38.22/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
- Incremental ROIC on the forecast capex ≈ 49% vs WACC 10.0% → above WACC — the build is value-creative.
Peer set
| Peer | EV/Rev | Fwd P/E | Growth | Op margin |
|---|---|---|---|---|
| NVDA | 18.8x | 22.7x | 10% | 66% |
| AVGO | 24.7x | 33.0x | 10% | 49% |
| MU | 15.0x | 10.5x | 10% | 68% |
| TXN | 15.4x | 39.8x | 10% | 38% |
| Median | 17.1x | 27.8x | — | — |
Implied prices at the peer medians: EV/Rev → $131 (no P/E-implied price — no forward-EPS basis at the peer step).
Weighted fair-value math
| Anchor | Value | Weight | Contribution |
|---|---|---|---|
| DCF | $68.78 | 47% | $32.10 |
| Scenario PWEV | $84.31 | 33% | $28.10 |
| Monte Carlo median | $79.24 | 20% | $15.85 |
| Triangulated | — | 100% | $76.05 |
Assumption Register
| Assumption | Value | Used in | Source |
|---|---|---|---|
| WACC | 10.0% | DCF discount rate | estimate (CAPM) |
| Terminal multiple | 26× | DCF exit value | estimate (peer-anchored) |
| Terminal growth | 2.5% | DCF Gordon terminal | estimate |
| SBC dilution | 0.0%/yr | PWEV, MC, DCF (charged once) | estimate (from SBC/rev) |
| EPS basis | consensus forward EPS (broker-adjusted, non-GAAP) | all forward P/E & scenario multiples | definition |
Sensitivity-ranked drivers (widest fair-value swing first): Revenue CAGR ±3pp (22.0); Terminal × ±15% (19.0); Op margin ±3pp (12.0); WACC ±1pp (7.0); Capex intensity ±15% (4.0).
Inputs, Sources & Confidence
Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)
| Input | Value | Type | Source | Confidence | Used in |
|---|---|---|---|---|---|
| Revenue TTM | $4.7B | reported fact | 10-K/10-Q via AV | High | Forecast base, EV/Rev |
| FY+1 guided revenue | $5.2B | company guidance | Company guidance | Medium | Forecast, SoP |
| Consensus FY EPS | $3.6506 | consensus estimate | Sell-side consensus via AV | Medium | Variant perception |
| Diluted shares | 0.573B | reported fact | 10-K via AV | High | Market cap, per-share |
| Net debt / cash | $5.295B | reported fact | Balance sheet via AV | High | EV, DCF equity bridge |
| WACC | 10.0% | house estimate | CAPM (beta/rf) | Medium | DCF discount rate |
| Terminal multiple | 26× | house estimate | Peer/historical range | Medium | DCF exit value |
| Terminal growth | 2.5% | house estimate | Long-run GDP+ | Medium | DCF Gordon terminal |
Research Provenance
| Field | Value |
|---|---|
| Quantitative engine | mch_stock_engine v2.0 |
| Research OS config | ros-1.19.0 |
| Analysis as-of | 2026-08-25 (prices 2026-08-24) |
| Narrative authorship | claude-opus-5 · Claude Code, supervised, drafted 2026-08-16 |
| Human review | Marinus 2026-08-16 |
| Evidence | 8/8 load-bearing inputs sourced; 13/14 mandated claims cited |
| QA | scanned post-emit by the document-QA layer; the publication label (Draft / Research / Decision-level) is stamped on the published page, not authored here |
Load-Bearing Assumptions
DCF: WACC 10.0%, terminal multiple 26×, FY+5 revenue $7B. Triangulation leans 47% on DCF, 33% on PWEV, 20% on the Monte Carlo median.
Appendix & audit trail — source log, data provenance, disclosures
Source Log
| Source | Type | Date | Used for | Reference |
|---|---|---|---|---|
| Alpha Vantage — GLOBAL_QUOTE / OVERVIEW | market data | 2026-08-24 | Price, market cap, EV, 52-week range, forward P/E | Alpha Vantage 2026-08-24 |
| Company income statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-08-24 | Revenue, gross/operating margin, EBIT, interest expense | INCOME_STATEMENT / latest annual |
| Company balance sheet (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-08-24 | Cash, debt, net debt, leases, equity, coverage | BALANCE_SHEET / latest annual |
| Company cash-flow statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-08-24 | Operating cash flow, capex, FCF, buybacks, dividends, SBC | CASH_FLOW / latest annual |
| Company earnings releases via Alpha Vantage | reported fact | 2026-08-24 | Reported EPS, surprise history | EARNINGS / quarterly |
| Sell-side consensus via Alpha Vantage | consensus estimate | 2026-08-24 | Forward revenue/EPS consensus, analyst count | EARNINGS_ESTIMATES |
| Earnings calendar via Alpha Vantage | market data | 2026-08-24 | Next earnings date, catalyst timing | EARNINGS_CALENDAR |
| Company guidance | company guidance | 2026-08-24 | FY guided revenue / non-GAAP EPS basis | company guidance / earnings call |
| MCH segment model (from filings & disclosures) | house estimate | 2026-08-24 | Segment revenue, margins, multiples, AI decomposition | company_context (authored, tagged) |
| MCH qualitative analysis | inference | 2026-08-24 | Moat, regulatory risk, scenario macro, catalysts | company_context enrichment (authored) |
| MCH investment thesis & falsification triggers | house estimate | 2026-08-24 | Thesis, anti-thesis, thesis-break signals | authored §5.3 |
Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.
Data Sources
- Prices, fundamentals, options chain, earnings — Alpha Vantage.
- Company filings (10-K / 10-Q) — SEC filings via EDGAR.
Disclosures & Limitations
This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.
- This report is produced by the MCH Advisory quantitative research engine — valuation, scenarios, Monte Carlo and the decision layer are generated systematically from the disclosed inputs and the archetype/industry driver sets, and reviewed rather than written name-by-name. Every figure reconciles to the appendix and every score exposes its inputs.
- No suitability assessment has been performed for any individual.
- Market data may be delayed or inaccurate; figures are as of the analysis date.
- Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
- Forecasts are uncertain; past performance is not indicative of future returns.
- The author or publisher may hold positions in securities mentioned.
- Users should verify information against primary sources (company filings) before acting.
- Investing involves risk of loss; there is no guarantee any target price is achieved.
- Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.